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Gold nanoparticles are currently investigated as theranostics tools in cancer therapy
due to their proper biocompatibility and increased efficacy related to the ease
to customize the surface properties and to conjugate other molecules. Betulin,
[lup-20(29)-ene-3β, 28-diol], is a pentacyclic triterpene that has raised scientific interest
due to its antiproliferative effect on several cancer types. Herein we described the
synthesis of surface modified betulin-conjugated gold nanoparticles using a slightly
modified Turkevich method. Transmission electron microscopy (TEM) imaging, dynamic
light scattering (DLS), scanning electron microscopy (SEM) and energy-dispersive X-ray
spectroscopy (EDX) were used for the characterization of obtained gold nanoparticles.
Cytotoxic activity and apoptosis assessment were carried out using the MTT and
Annexin V/PI apoptosis assays. The in vitro results showed that betulin coated gold
nanoparticles presented a dose-dependent cytotoxic effect and induced apoptosis in
all tested cell lines.
Keywords: gold nanoparticles, betulin, skin, apoptosis, melanoma
INTRODUCTION
Metallic nanoparticles are currently investigated as drug delivery systems and/or diagnostic agents
in cancer therapy due to their unique physico-chemical properties and their ability to improve
drug selectivity against cancer cells (Ahmad et al., 2010). Gold nanoparticles were described as
biocompatible and highly effective when compared to other metallic nanoparticles applied in
antitumor therapy as drug nanocarriers or hyperthermia agents (Khan et al., 2014). Basically,
gold nanoparticles provide multiple assets for biomedical applications, as: controlled synthesis,
easy functionalization, passive/active targeting properties and the ability to transport and protect
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large amounts of loaded drugs (Ahmad et al., 2010). The
use of gold nanoparticles as drug delivery platforms can
be accomplished via conjugating the active drugs with gold
nanoparticles usually by the use of spacers such as thiolated
polyethylene glycols that covalently bind to gold; the final goal
being the achievement of plasmatic stability and selectivity, as
well as the ability to release the active drug as a result of
metabolic processes (Cui et al., 2017). Another approach is
the direct deposition of the active compound on the surface
of gold nanoparticles (Elbialy et al., 2014), probably for the
fact that gold nanoparticles might be considered as centers of
formation of a new phase due to adsorption of precipitated
substances. Several anticancer drugs such as doxorubicin (Jang
et al., 2013), recombinant human endostatin (Li et al., 2016) and
paclitaxel (Heo et al., 2012; Paciotti et al., 2016) were loaded
in gold nanoparticle-based delivery systems, thus achieving
significantly improved nuclear uptake, targeted release and
an overall increased antitumor efficacy. In fact, a certain
level of selectivity provided by the enhanced permeability
and retention effect, which occurs for all nanosized drugs, is
caused by the leaky vasculature within tumor microenvironment
(Nakamura et al., 2016). The biocompability and tunable
optical and electronic properties make gold nanoparticles
suitable agents in the biomedical field (Gao, 2013; Piperigkou
et al., 2016; Engin et al., 2017). In particular, there are
a few characteristics such as small size, inert nature and
the opprtunity to bind to multiple surface ligands which
allow gold nanoparticles to penetrate inside cells and deliver
their payloads without eliciting significant immune response
(Garrido et al., 2015). As a result, several gold nanoparticle
based formulations have reached preclinical or clinical trials
as theranostic agents in cancer therapy (Pedrosa et al.,
2015).
Betulin, [lup-20(29)-ene-3β,28-diol], is a pentacyclic
triterpene that has drawn scientific interest due to its multiple
biologic activities, mainly anti-inflammatory and antitumor
(Alakurtti et al., 2006); in spite of this promising pharmacological
profile, its clinical use is severely restricted by its very poor
bioavailability and bio-distribution in direct correlation to its
low water solubility (Dra¸g-Zalesin´ska et al., 2017). In an effort
to overcome this drawback, several nanoformulations with
betulin have been developed such as cyclodextrin complexes
(Soica C. et al., 2012), polymer-liposome nano-complexes (Cho
et al., 2007), nanoemulsions (Dehelean et al., 2013), carbon
nanotubes (Saudagar and Dubey, 2014), nanostructured carbon
sorbent (Lavrenov et al., 2015); all studies reported an improved
pharmacokinetic profile of the active compound therefore an
increased bioavailability.
In the current study, we report the preparation of betulin-
conjugated gold nanoparticles by using sodium citrate as
both reducing agent and stabilizer; two types of conjugated
nanoparticles were synthesized, with and without thiolated
polyethylene glycol, respectively. The physico-chemical
parameters of the final nanoparticles were assessed by employing
various analytical techniques due to the fact that nanoparticles’
size, shape and stability hugely influence their future biological
behavior (Dreaden et al., 2012). The in vitro biological activity of
betulin-conjugated gold nanoparticles was further analyzed by
means of MTT and Annexin V/PI assays.
MATERIALS AND METHODS
Materials
Betulin, nitric acid, hydrochloric acid and L-Cysteine
hydrochloride were purchased from Fisher Scientific
(Loughborough, United Kingdom). Chloroauric acid
(HAuCl4), trisodium citrate dihydrate (C6H5O7Na3·2H2O),
and poly(ethylene glycol) 2-mercaptoethyl ether acetic acid
(HOOC-Peg-SH, MW 3500) were purchased from Sigma-
Aldrich (Taufkirchen, Germany) and used as received. The
deionized water was prepared by using the Ultrapure, Millipore R©
Direct-Q R© 3 with UV radiation.
Gold Nanoparticles Synthesis
The synthesis of gold nanoparticles was conducted according
to the previously published Turkevich procedure with slight
modifications (Sutherland and Winefordner, 1992; Kim et al.,
2007). Briefly, 380 ml deionized water were heated to boiling
under vigorous stirring; HAuCl4 solution (a volume of 1.44 ml –
4% concentration) was added followed by 18.6 ml of aqueous
solution containing 175 mg of trisodium citrate dihydrate
(C6H5O7Na3 ·2H2O) while maintaining the boiling temperature
for approximately 10–15 min. The molar ratio was 1:3.5
(HAuCl4: C6H5O7Na3 ·2H2O). The transparent, ruby-red
solution was allowed to cool at room temperature. Purification
was accomplished by centrifugation (30 min at 15000 rpm)
followed by repeated washing with deionized water. The final
product was lyophilized and resuspended in methanol for further
investigation. PEG-surface modified gold nanoparticles were
prepared by adding 10 mg of HOOC-PEG-SH to 100 ml of
aqueous gold nanoparticle solution (Alkilany et al., 2015), under
continuous stirring for about 30 min. The resulting solution was
centrifuged for 30 min at 15000 rpm and the final product was
lyophilized and resuspended in the required solvent.
Betulin Loading Onto Gold Nanoparticles
Betulin (Bet) loading was accomplished by adding, under
continuous stirring, 2 ml of betulin solution in methanol
(1 mg/ml) to 2 ml colloidal gold solution in methanol, achieving
a relative betulin:gold molar ratio (gold molarity related to
chloroauric acid used for the reduction) of 1:4; methanol was
selected as a dispersion medium for both AuNP and betulin
in order to avoid betulin precipitation. The dispersion medium
was subsequently removed by vacuum evaporation; the resulting
powder was resuspended in the desired solvent.
UV-Vis Spectroscopy
The UV-Vis analysis was performed using a UV-VIS
spectrophotometer, series T80 (PG Instruments LtD,
United Kingdom), with a quartz cuvette at 25◦C temperature
in the wavelength range of 400–750 nm. In order to evaluate
the gold nanoparticles formation process, spectrophotometric
measurements were achieved regularly (each minute) throughout
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the synthesis. The stability of the colloidal gold solution was
evaluated by spectrophotometry daily for 7 days, the samples
being stored in the refrigerator (4◦C) throughout the experiment.
FTIR Spectroscopy
The Fourier-transform Infrared Spectroscopy (FTIR) spectra
were recorded using a Shimadzu Prestige-21 spectrometer; the
samples were processed as potassium bromide pellets within the
range of 400–4000 cm−1 at 4 cm−1 resolution.
Quantification of Gold From Gold
Nanoparticles Using Inductively Coupled
Plasma – Mass Spectrometry (ICP – MS)
Sample Preparation
A volume of 1 mL mixture of nitric acid and hydrochloric acid
(25:75, %v/v) containing 600 ppb of internal standard (Iridium)
was added to 20 µL of gold nanoparticles suspension. The
mixture was incubated in a fume hood overnight, at room
temperature. After incubation, the suspension obtained was
further diluted in a mixture of 1% hydrochloric acid and 1%
L-Cysteine at a 1:60 ratio. The final dilution of the initial sample
was 1:300.
Gold Determination
Analysis was performed using a XSeries 2 ICP-MS coupled
to a Cetac ASX-520 autosampler (Thermo Fisher Scientific,
United States). The acquisition mode consisted in peak jumping
with two channels, one mass per channel: 193Ir (Iridium) and
106Au (Gold). Acquisition parameters were: dwell time – 100 ms
for 106Au and 50 ms for 193Ir, separation AMU – 0.02, number
of sweeps – 50, the acquisition time – 7 s. Iridium was set as
internal standard and gold for quantitation. RF power was set at
1400 W and nebulizer set concentric at 35 psi with 1 mL/min
flow. Sample uptake delay was set with a minimum of 40 s
and a maximum of 50, while the washout maximum delay was
set at 65 s. The washing solution used was 1% hydrochloric
acid and 0.1% L-Cysteine. The blank sample consisted of 1%
hydrochloric acid, 1% L-Cysteine and 10 ppb Iridium. The limit
of detection (LOD) was calculated using 3.14σ of 7 consecutive
blank samples and the limit of quantification was calculated using
10σ of 7 consecutive blank samples. For calibration, the curve
fitting options were: line fit – linear, weight – none, and force –
through blank.
Particle Size and Zeta Potential Analysis
In order to determine the size and stability of the aqueous
solutions for the studied samples, Vasco Particle Size Analyzer
and Wallis Zeta-potential Analyzer (Cordouan Technologies,
France) were utilized. For data acquisition, the following
parameters for the Size Analyzer were preset: temperature 25◦C,
time interval 14 µs, number of channels 337, laser power 95%,
DTC position down, acquisition mode continuous, analysis mode
Cumulants and for the Zeta potential Analyzer: temperature
25◦C, plastic cuvette, medium resolution, laser power 75%,
electrode distance 5 mm, Henry function Huckel.
TEM, SEM-EDAX Analysis
The morphology of the sample was characterized by transmission
electron microscopy (TEM) using a FEI Tecnai 12 Biotwin
microscope.
SEM-EDAX analysis was carried out using an EDAX detector
(ZAF Quantification – Standardless, Element Normalized) with
FEI Quanta 250 microscope. SEM analysis parameters were: HV
mode, 30 kV, ETD (Everhart-Thornley detector for secondary
electrons), two magnification orders, one for a general overview
image/measurements and another one for higher surface
topography sides analysis. The identified chemical species were
expressed in weight percent (Wt %) or atomic percent (At %).
Cell Culture
Human melanoma cell line – A375 (ATCC R© CRL-1619TM)
was purchased from the American Type Culture Collection
(ATCC, Manassas, VA, United States); B164A5 (Sigma Aldrich
94042254) murine melanoma cell line was acquired from
Sigma-Aldrich (Taufkirchen, Germany); 1BR3 human skin
fibroblast (ECACC 90011801) was obtained from the European
Collection of Authenticated Cell Cultures (ECACC, Salisbury,
United Kingdom); the HaCaT (human keratinocyte) cells were
kindly provided by the University of Debrecen, Hungary.
A375, B164A5 and HaCaT cells were cultured as a monolayer
in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma-Aldrich, Taufkirchen, Germany) supplemented with
10% fetal bovine serum (FBS; Gibco, ThermoFisher Scientific)
and 1% Penicillin/Streptomycin mixture (Pen/Strep, 10,000
IU/ml; Sigma-Aldrich, Taufkirchen, Germany). 1BR3 cells
were grown in Eagle’s Minimum Essential Medium (EMEM;
ATCC) supplemented with 15% fetal bovine serum (FBS;
Gibco, ThermoFisher Scientific) and 1% Penicillin/Streptomycin
mixture (Pen/Strep, 10,000 IU/ml; Sigma-Aldrich, Taufkirchen,
Germany). The cells were kept in standard conditions
(humidified atmosphere containing 5% CO2, 37◦C).
Cytotoxicity Assay
The in vitro cytotoxicity was determined by means of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
method. In brief, HaCaT, 1BR3, A375 and B164A5 cells were
seeded in 96-well plates at an initial density of 1 × 104 cells/well
and allowed to attach. Next, the old medium was removed
and a fresh one was added containing AuNP formulations
in dimethyl sulfoxide – DMSO (AuNP, AuNP + Bet, AuNP
Peg, and AuNP Peg + Bet) at the final concentration of
10 and 50 µM equivalent of betulin, and the cells were
incubated for 24, 48, and 72 h. The control cells were treated
with the same amount of DMSO, the highest concentration
of DMSO present in the medium being 0.5%. A volume
of 10 µL MTT reagent (5 mg/mL) was added in each
well. During a 4 h contact period, the intact mitochondrial
reductase converted and precipitated MTT as blue crystals. The
precipitated crystals were dissolved in 100 µL of lysis solution
provided by the manufacturer (Sigma-Aldrich). Finally, the
reduced MTT was spectrophotometrically analyzed at 570 nm,
using a microplate reader (xMark Microplate Spectrophotometer,
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Bio-Rad). The in vitro experiments were carried out in
triplicate.
Annexin V/PI Apoptosis Assay
For the flow cytometric analysis of cell apoptosis, an Annexin
V-FITC kit (Invitrogen, ThermoFisher, Vienna, Austria) was
used. A number of 5 × 105cells/well were seeded onto
6-well plates (Greiner bio-one) and incubated with the tested
compounds for 72 h. The selected concentrations were 10
and 50 µM, which were obtained by successive dilutions into
the culture medium starting from a stock solution of 10 mM
in DMSO. Untreated cells were used as control; cells treated
with DMSO were used as solvent control. The highest DMSO
concentration (0.5%) in the medium did not exhibit any
significant effect on cell apoptosis. After trypsinization, cells
were collected, resuspended in 500 µL Phosphate Buffer Saline
(Sigma-Aldrich) and centrifuged for 5 min at 1500 RPM. The
next step consisted in performing the flow cytometric studies
according to the manufacturer’s protocol: 2–5 × 105cells were
two times washed in 1 × Annexin V Binding Buffer, centrifuged
at 1500 RPM for 5 min, resuspended in the binding buffer
and incubated with 5 µL of Annexin V-FITC for 15 min in
the dark. After washing the cells with 200 µL specific binding
buffer and centrifugation, the cells’ pellet was resuspended in
190 µL binding buffer, and 10 µL of PI solution was added
immediately prior to analysis by flow cytometry. The data were
achieved using a FACSCalibur flow cytometer (Becton Dickinson,
Franklin Lakes, NJ, United States). The results were analyzed
using Flowing Software 2.5.1.
RESULTS
UV-Vis Spectrophotometry
Along synthesis, UV-Vis spectrophotometry revealed the shift
of the absorption maximum toward larger wavelengths. The
formation of gold nanoparticles was monitored in terms of color
change and the UV-Vis analysis generated a single absorption
peak for each type of gold compounds that in the end of the
synthesis were located in the interval of 520–530 nm, thus
indicating the formation of gold nanoparticles and justifying
the ruby-red color of the final solution (Figure 1A). The
corresponding wavelengths for maximum peak absorption were:
526 nm for AuNP, 528 nm for AuNP + Bet, 529 nm for AuNP
PEG and 530 nm for AuNP PEG + Bet (Figure 1A). Also,
stability studies were conducted at 7 days, 1 and 3 months,
respectively, after the nanoparticle synthesis, by employing
UV-Vis spectrophotometry; the absorption maximum remains
situated around 520 nm thus indicating insignificant changes of
the AuNP dimensions.
FTIR Spectroscopy
FTIR analysis revealed the characteristic bands of the various
AuNP specimens (Figure 1B). The vibrational spectra were
recorded in the range of 400–4000 cm−1. The band located at
3421/3431/3436 cm−1 identified in all the studied samples can
be assigned to the O-H stretching vibration (Schrader, 1995),
hydroxyl bonds being present in both citrate and betulin. The
band located at 2945 cm−1 attributed to the =C-H stretch and
the one at 2876 cm−1 assigned to the C-H stretch, indicate the
presence of betulin (Joshi et al., 2013; Wang et al., 2014) in
the sample AuNP Peg Bet; these bands were not present in the
other two samples that lack betulin. The other bands assigned to
betulin, in the literature, are overlapped with the ones attributed
to the other components present in the sample.
The intense absorption peaks located around 1590 and
1395 cm−1 belong to the symmetric and asymmetric stretching
vibration of COO− in trisodium citrate (Bai et al., 2010; Mohan
et al., 2013). Due to the fact that these bands are shifted as
compared to the ones reported for the pure trisodium citrate
(Bai et al., 2010), one can assume the conjugation of the carboxyl
groups at the surface of gold nanoparticle. In addition, another
typical band located around 620 cm−1 indicate the presence of
citrate alkyl groups. The band located at 1092/1098 cm−1 is
characteristic for the C-O-C stretching vibration (Vonnemann
et al., 2014), certifying the presence and functionalization of
PEG-SH.
Gold Determination by ICP-MS
The gold LOD (limit of detection) was calculated at 0.0035 µg/L
and the LOQ at 0.0111 µg/L. Calibration correlation coefficient
was 0.9998. The dilution factor was applied to the obtained
results. The quantitative results are displayed in Table 1.
Particle Size and Zeta Potential Analysis
The results of the particle size and zeta potential are presented
in Table 2. The Cumulants analysis provided by the Particle Size
Analyzer offers an average size of the particles in the analyzed
sample. One can notice a slight dimension growing tendency
from AuNP to AuNP + Bet and AuNP Peg-SH that can be
explained by the addition of Bet and Peg-SH, respectively in
the sample. AuNP Peg-SH + Bet show the largest dimensions
(88± 10 nm).
TEM, SEM-EDX Analysis
TEM analysis revealed an average particle diameter situated
around 14–15 nm for all samples (Figure 2). In addition, the
analysis highlighted the spherical shape of the gold nanoparticles
regardless of their composition.
Figure 3 shows the SEM image of the sample AuNP; one can
notice spherical shapes of various sizes (42.03–60.64 nm) with
contact facets among them and also an agglomeration tendency.
The energy dispersive X-ray analysis (EDX) (Figure 4) was
employed to determine the elemental composition of the sample
(Table 3); the analysis showed the presence of C, O, Na, Au, and
Cl in the samples thus confirming nanoparticle formation.
Cytotoxicity Assay
The percentage of viable cells after incubation with test
compounds was calculated related to the solvent control (DMSO
used for samples preparation). Cell viability results obtained on
tumor cell lines are depicted in Figure 5.
At 24 h post-stimulation AuNP and AuNP Peg induced a
slightly increase in B164A5 murine melanoma cells viability,
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FIGURE 1 | Recorded UV-Vis spectra for AuNP formulations: AuNP, AuNP + Bet, AuNP Peg and AuNP Peg + Bet (A) and FTIR spectra of AuNP formulations (B).
TABLE 1 | Gold concentration of nanogold samples determined by ICP-MS.
Sample Concentration (µg Au/mL suspension)
AuNP 30.2511
AuNP Peg 35.3736
AuNP + Bet 28.4274
AuNP Peg + Bet 28.6324
TABLE 2 | Particle size and zeta-potential values of the nanogold samples.
Sample Particle size (nm) Zeta-potential (mV)
Cumulants
Mean ± SD Intensity
AuNP 43 ± 5 0.8 −52.87
AuNP + Bet 66 ± 7 0.7 −46.19
AuNP Peg 67 ± 8 0.8 −27.59
AuNP Peg + Bet 88 ± 10 0.8 −34.76
SD, standard deviation.
whereas on A375 elicited a modest decrease in cell viability.
AuNPs loaded with betulin induced a decrease in cell viability
in a dose-dependent manner, the decrease being more potent
in the case of A375 human melanoma cells (Figure 5). The
cytotoxic effect induced by both AuNPs and AuNP Peg loaded
with betulin was slightly higher as compared with the one
recorded for betulin alone at the same concentration. At 48 h
post-stimulation, AuNP and AuNP Peg did not significantly
affect cancer cell viability. A small decrease of cell viability
was noticed only in the case of B164A5 cells, at the highest
tested concentration (50 µM). Betulin-conjugated AuNPs and
AuNP Peg proved to be significantly toxic mainly for human
melanoma cells – A375 when compared with betulin alone at
48 h post-stimulation. Similar effects were noticed in the case
of murine melanoma cells – B164A5, showing that betulin-
conjugated gold nanoparticles exhibit a stronger in vitro cytotoxic
effect compared to betulin. Even after 72h incubation, AuNP
and AuNP Peg lacked any cytotoxic activity against A375 cells,
moreover a slightly stimulatory effect was recorded; for B164A5
cells a decrease in cell viability was reported when the highest
concentration (50 µM) was used. However, on both types of
melanoma cells, betulin-conjugated gold nanoparticles elicited
a decrease in cell viability in a dose-dependent manner; their
cytotoxicity was significantly higher related to betulin as such
(Figure 5).
All nanogold formulations were also assessed for their
cytotoxicity against two non-malignant cell lines (HaCaT, 1BR3).
The results are presented in Figure 6. HaCaT cells stimulation
with AuNP and AuNP Peg led to increased cell viability at all
three evaluated time points (24, 48, and 72 h); the 1BR3 cells
proved to be more sensitive in a dose- and time-dependent
manner, the lowest viability percentage being recorded for the
highest concentration (50 µM) after 72 h incubation. Treatment
with betulin-conjugated gold nanoparticles reduced cell viability,
in particular for the 1BR3 cell line (skin fibroblasts) in a dose-
dependent manner, the highest cytotoxic effect being recorded
at 48 h. Betulin alone proved to be less toxic on both human
keratinocytes – HaCat and fibroblasts – 1BR3 cell lines by
comparison with betulin loaded gold nanoparticles. Seventy two
hour stimulation with AuNP+ Bet and AuNP Peg+ Bet induced
a significant decrease in 1BR3 cell viability, in particular at the
highest tested concentration (50 µM), whereas the keratinocytes
exhibited higher viability rates.
Annexin V/PI Apoptosis Assay
Figure 7 represents the percentage of early apoptotic cells of
HaCaT, 1BR3, B164A5 and A375 cell lines after 72 h of incubation
with the tested substances while Figure 8 exhibits representative
dot plots for the flow cytometric Annexin V/PI analysis of each
cell line after 72 h of treatment. One can notice that AuNP and
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FIGURE 2 | Transmission electron microscopy (TEM) analysis and particle size distribution for nanogold samples: AuNP (A), AuNP Peg (B), AuNP + Bet (C), AuNP
Peg + Bet (D).
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FIGURE 3 | Scanning electron microscopy (SEM) analysis of gold
nanoparticles sample (AuNP).
AuNP Peg had no semnificative effect on cell apoptosis in case of
B164A5 and A375 melanoma cell lines, while in case of HaCaT
and 1BR3 cells a slight pro-apoptotic effect was observed for
AuNP Peg. However, when betulin was included in nanoparticles,
a strong dose-dependent apoptotic effect was observed for all cell
lines.
DISCUSSION
The use of gold nanoparticles as carriers for betulinic acid was
previously reported as effective in the management of cervical
cancer (Jiang and Wang, 2016), the drug transport into the
cancer cells increasing due to nanoparticle endocytosis. In the
current paper we accomplished the synthesis of betulin loaded
gold nanoparticles based on the hypothesis that gold conjugation
will improve drug bioavailability and, consequently, its anticancer
properties.
The synthesis of the gold nanoparticles was conducted by
the slightly modified Turkevich method which involved the use
of sodium citrate to reduce the chloroauric acid to metallic
gold; the method allows the formation of almost monodisperse
spherical gold nanoparticles with diameters smaller than 50 nm
(Stiufiuc et al., 2013). The selection of the synthesis method
was determined by the fact that unlike other more complicated
shapes, spherical nanoparticles are easily synthesized using
weakly bonded (i.e., hydrogen bonds) stabilizing ligands which
enable ligand exchange; therefore, spherical gold nanoparticles
are suited as drug delivery agents (Dreaden et al., 2012).
In addition, spherical nanoparticles show superior celullar
uptake to nanorods (Arvizo et al., 2010). The resulting gold
nanoparticles exhibit modified surfaces, displaying attached
citrate moieties that also act as stabilizer against particle
FIGURE 4 | EDX spectra of gold nanoparticles sample (AuNP).
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TABLE 3 | Elemental composition of the Au-NPs.
Element Wt% At% K-Ratio Z A F
C K 21.86 31.27 0.0469 1.0384 0.2066 1.0005
O K 38.14 40.96 0.0962 1.0238 0.2460 1.0008
NaK 34.85 26.04 0.0920 0.9618 0.2745 1.0002
AuM 2.70 0.54 0.0193 0.7834 1.1567 1.0002
ClK 2.45 1.19 0.0152 0.9409 0.6594 1.0000
Total 100.00 100.00
aggregation (Dobrowolska et al., 2015). The colloidal gold
solution with a diameter ranging between 5 and 60 nm is stable
without adding a supplementary stabilizer (Verma et al., 2014).
An important issue in nanoparticle administration is the
intervention of the reticuloendothelial system (RES); previous
reports mentioned the passive targeting of RES by gold
nanoparticles ranging between 10 nm and 250 nm up to 46%
(Watkins et al., 2015). For this reason, PEG coating can be
used to increase biocompatibility and circulation time as well
(Watkins et al., 2015) due to the tight association of the ethylene
glycol units with water molecules, the resulting hydrating layer
preventing subsequent clearance (Blanco et al., 2015). We used
as capping agent a thiolated PEG with medium molecular weight
(3500 Da) based on a 2013 study which revealed that, although,
high molecular weight PEG are more efficient stabilizers than
low molecular weight PEG, the latter produces higher saturated
capping density which allows a more efficient functionalization
of gold nanoparticles (Wang et al., 2013). The thiolated PEG used
in our experiments also presented a carboxyl termination that
induced high stability, biocompatibility and excellent binding
properties (Park et al., 2013).
The formation of the stabilized gold nanoparticles was
monitored at regular time interval throughout the synthesis by
UV-Vis spectroscopy. The presence of the absorption maximum
in the range of 500–550 nm clearly indicates the formation of the
gold nanoparticles as reflected by the color change of the gold
colloidal solution from colorless to ruby-red (Singh et al., 2014).
There is a direct correlation between the wavelength and the
particle size and between the width of the peak and the particle
size distribution as well (Huang and El-Sayed, 2010; Dhamecha
et al., 2016); therefore we can state that the final gold colloidal
solution contains nanoparticles with a narrow size distribution,
results confirmed by the other methods applied in the present
work.
The FTIR combined with ICP-MS analysis confirmed the
presence of gold, PEG and betulin in the respective samples
(Figure 1B and Table 1); all the absorption bands were attributed
to vibrational modes according to the literature (Schrader, 1995;
Vonnemann et al., 2014). The results are in agreement with
the other analytical methods thus providing evidence for the
formation of nanoparticles carrying a stabilizer.
The gold nanoparticles were characterized by employing
consecrated analytical techniques such as TEM imaging and
DLS measurements. The images obtained as a result of TEM
analysis do not capture the organic exterior layers at the gold
surface; TEM provides accurate information only regarding the
metallic core. The average dimension of the gold nanoparticles
is located around values of 14–15 nm as revealed by TEM
analysis. Following DLS measurements one can notice a larger
diameter of nanoparticles, around 50 nm in case of naked AuNP
or betulin conjugated-AuNP due to an electric dipole at the
metallic surface as a result of water dispersion (Spaas et al., 2016).
When PEG was used as coating agent, TEM analysis indicated
the same dimension of 14–15 nm for the metallic core while
the DLS measurement provided an average dimension of 70 nm
presumably attributed to the hydrated chains of PEG covalently
bonded to the surface. The nanoparticles’ size plays an important
role in tumor uptake and tissue penetration; Huo et el. (2013)
reported that in spite of the limitations of drug delivery deep
into the tumor tissue, imposed by tumor microenvironment,
nanoparticles with an average diameter of 50 nm were superior
to larger ones (100 nm diameter) in terms of tissue permeability.
Moreover, the passive targeting of solid tumors was additionally
facilitated by the enhanced permeation and retention effect (EPR)
(Huo et al., 2013); nanoparticles with small sizes (below 50 nm)
show a wider biodistribution into the human body as compared
with larger ones (i.e., 200 nm) (Garrido et al., 2015). These
nanoparticles are able to penetrate the blood brain barrier and
have the longest half-life when coated with PEG (Arvizo et al.,
2010). In light of these findings the average dimensions of 15 and
50 nm for naked AuNP and AuNP Peg, respectively, obtained
during the course of our experiments, are appropriate in terms
of cancer cell penetration for future therapeutic approaches.
The zeta potential provides an electrostatic stabilization
factor of suspended nanoparticles and characterizes their surface
charge, highly depending on other factors such as solvent, pH,
functional groups (Zhang et al., 2014). Literature reports that
a zeta potential value ranging from −30 mV to 30 mV is
specific for a stable dispersed system due to rejection between
nanoparticles. The values reported in our experiments are
consistent with the literature specification, all dispersed systems
revealing physical stability during storage, in particular in the
presence of an additional stabilizer such as thiol-PEG-COOH
(Zhang et al., 2014). The increase of the zeta potential values
(Table 2) for the PEGylated AuNP reflect the capping of the
metallic surface with PEG-SH (through covalent Au-S bonding)
and with betulin, presumably through electrostatic or hydrogen
bonds (formed between the carboxyl termination of the PEG-SH
and the hydroxyl group of betulin). The attachment of the drug
molecule through non-covalent interactions such as electrostatic
or hydrogen bonds provides nanoparticles’ stability and the
ability to release the conjugated drug in acidic environments (i.e.,
cancer cell) as a result of carboxyl ionization (Madhusudhan et al.,
2014).
The gold nanoparticles (AuNP, AuNP Peg with or without
betulin load) synthesized in the present study were assessed
in terms of cytotoxicity and induction of apoptosis in non-
malignant (human keratinocytes – HaCaT and fibroblasts –
1BR3) and cancer cells (human – A375 and murine – B164A5
melanoma). Previous studies demonstrated the effectiveness of
gold nanoparticles in damaging cancer cells (Xu et al., 2012; Li
et al., 2017; Lu et al., 2017; Lopez-Chaves et al., 2018) via several
pathways, including: cell death, stimulation of pro-apoptotic
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FIGURE 5 | In vitro cytotoxicity assessment of naked AuNPs/AuNP Peg and betulin conjugated gold nanoparticles (10 and 50 µM) on tumor cells: murine – B164A5
and human – A375 melanoma cells at 24, 48, and 72 h post-stimulation by the means of MTT assay. The results are expressed as cell viability percentage (%)
related to control cells (stimulated with dimethyl sulfoxide – DMSO). The data represent the mean values ± SD of three independent experiments performed in
triplicate. One-way ANOVA analysis was applied to determine the statistical differences followed by Tukey post-test (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).
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FIGURE 6 | In vitro cytotoxicity assessment of naked AuNPs/AuNP Peg and betulin conjugated gold nanoparticles (10 and 50 µM) on non-malignant human cells:
keratinocytes – HaCat and fibroblasts – 1BR3 melanoma cells at 24, 48, and 72 h post-stimulation by the means of MTT assay. The results are expressed as cell
viability percentage (%) related to control cells (stimulated with dimethyl sulfoxide – DMSO). The data represent the mean values ± SD of three independent
experiments performed in triplicate. One-way ANOVA analysis was applied to determine the statistical differences followed by Tukey post-test (∗p < 0.05;
∗∗p < 0.01; ∗∗∗p < 0.001).
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FIGURE 7 | Summarized results of early apoptotic cells percentage of HaCaT, 1BR3, B16 4A5 and A375 cell lines after 72 h of treatment with the tested
substances. The results are representative of three independent experiments in triplicate and expressed as mean ± SD.
protein (Bax) expression, inhibition of tumor cells migration
and motility (Lu et al., 2017), suppression of epithelial-to-
mesenchymal transition (Li et al., 2017) and oxidative reactive
species (ROS) production after short-exposure time (Lopez-
Chaves et al., 2018). It is considered that the appropriate size
of gold nanoparticles for tumor therapy in humans is 50 nm,
whereas the size required for the ones employed as diagnostic
tools is smaller −20 nm (Agunloye et al., 2017). In a recent
study, Lu and co-workers showed that AuNPs of different sizes
(1–3; 3–5, and 10–15 nm) exerted cytotoxic effects on a murine
melanoma cell line B16F10 in a dose-dependent manner, the
nanoparticles with the smallest size being the most cytotoxic.
Moreover, in the same study, it was observed that the smallest
AuNPs (1–3 nm) were highly toxic against non-malignant
human keratinocytes (HaCaT) cells after 72 h treatment as
compared to the bigger ones (10–15 nm) which were barely
cytotoxic (Lu et al., 2017). Our results are somehow in agreement
with the aforementioned data, since the AuNPs (14–15 nm –
dimensions of the metallic core) induced a time and dose-
dependent cytotoxicity in human (A375) and murine (B164A5)
melanoma cells, the most significant effect being observed at the
highest concentration tested – 50 µM (Figure 5). In the case of
AgNP PEG coated, there were no significant changes regarding
the viability of melanoma cells. Stimulation of HaCaT cells with
both AuNP and AuNP PEG coated was associated with a lack
of toxicity even at the highest doses tested (Figure 6), indicating
a safe profile, results that are consistent with the data from the
literature. Assessment of the cytotoxic effects of AuNP and AuNP
PEG coated on human fibroblasts – 1BR3 led to a different result
concerning AuNP stimulation which exerted a dose and time-
dependent toxic effect (Figure 6). Our results proved that AuNP
PEG coated could be considered safe for human fibroblasts, since
no significant toxic effect was recorded (Figure 6).
The efficacy of betulin as an anticancer agent has been
previously reported by our group in various tumor cell lines, such
as skin epidermoid carcinoma (A431), cervix adenocarcinoma
(HeLa), breast carcinoma (MCF7) and murine melanoma
(B164A5) (Alakurtti et al., 2006; Dehelean et al., 2012; Soica C. M.
et al., 2012). Furthermore, there are studies indicating that betulin
decreases melanoma cells viability and induces apoptosis (G-361
human melanoma cells, (Orchel et al., 2014); B164A5 and B16F0
murine melanoma cells, (Pfarr et al., 2014, 2015)). One of the
main disadvantages of this compound is represented by its poor
water solubility that diminishes its bioavailability (Dehelean et al.,
2013). In an attempt to improve the solubility, our group has
obtained different betulin formulations, namely nanoemulsions
(Dehelean et al., 2013) and cyclodextrin complexes (Soica C.
et al., 2012) that proved an enhanced therapeutic activity. Also,
the literature contains a few reports concerning the synthesis of
betulin nanoformulations such as carbon nanotubes or polymeric
vectors (Table 4) with antiproliferative activity. One can notice
that, despite the intrinsic antiproliferative activity of pure betulin,
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FIGURE 8 | Representative dotplots of apoptotic cells stained with Annexin V-FITC/PI and analyzed by flow cytometry after 72 h treatment, grouped as follows:
(A) HaCat: Control, AuNP 50 µM, AuNP Peg 50 µM, AuNP Peg + Bet 50 µM; (B) 1BR3: Control, AuNP 50 µM, AuNP Peg 50 µM, AuNP Peg + Bet 50 µM;
(C) B164A5: Control, AuNP 50 µM, AuNP Peg 50 µM, AuNP Peg + Bet 50 µM; and (D) A375: Control, AuNP 50 µM, AuNP Peg 50 µM, AuNP Peg + Bet 50 µM.
Selection of the dotplots was based on the significant pro-apoptotic effects induced by test compounds at 50 µM.
its nanoformulations provide improved biological effects either
in vivo (nanoemulsions) or in vitro (cyclodextrin complexes,
carbon nanotubes, polymeric vectors).
Another method to increase betulin solubility in aqueous
solutions and to augment its bioavailability was proposed in
the current study, by manufacturing betulin-conjugated gold
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TABLE 4 | Biological activities of different betulin formulations.
Formulation In vitro cytotoxic/antiproliferative activity In vivo antitumor activity Reference
Betulin No significant cytotoxic effect on J774A.1 macrophage
cell line (IC50 value is 211.05 ± 7.14 µg/ml)
Saudagar and Dubey,
2014
Betulin Decreased viability of B164A5 murine melanoma cells
(52% ± 0.09% viable cells).
Soica C. et al., 2012
Betulin Cytotoxic effect on cervix carcinoma HeLa cells,
hepatoma HepG2 cells, lung adenocarcinoma A549
cells, and breast cancer MCF-7 cells (IC50 values
ranging from 10 to 15 µg/mL); Moderate anticancer
activity in hepatoma SK-HEP-1 cells, prostate
carcinoma PC-3 cells, and lung carcinoma NCI-H460
cells (IC50 values ranging from 20 to 60 µg/mL)
Li et al., 2010
Betulin Antiproliferative effect on Neuroblastoma SK-N-AS
cells, glioma C6 cells,
rhabdomyosarcoma-medulloblastoma TE671 cells,
colon adenocarcinoma HT-29 cells, breast carcinoma
T47D cells, thyroid carcinoma FTC238 cells, lung
carcinoma A549 cells, multiple myeloma RPMI8226
cells, T cell leukemia Jurkat 1E.6 cells, ovarian
carcinoma HPOC cells, cervical carcinoma HPCC cells
and glioblastoma multiforme HPGBM cells (IC50 values
ranging from 2.5 to 10.3 µM)
Rzeski et al., 2009
Betulin Antiproliferative effect on A431 (skin epidermoid
carcinoma), HeLa (cervix adenocarcinoma) and MCF7
(breast adenocarcinoma) (IC50 values are 6.76, 6.67,
and 8.32 µM)
Antiangiogenic effect by reducing the newly formed
capillaries and affecting the normal function of
endothelial cells.
Dehelean et al., 2012
Betulin nanoemulsion BetNE reduced skin tumor apparition and promotion in
the two-stage skin carcinoma (DMBA and TPA
application);
Increased basal and ADP-stimulated respiration in
isolated liver mitochondria from treated mice. In CAM
assay – BetNE decreased the density of capillaries vs.
NE alone.
Dehelean et al., 2013
Betulin complexes with
cyclodextrins
Decreased B164A5 murine melanoma cells viability
(62% ± 0.25% viable cells); Increased number of
apoptotic cells (5.38% vs. control 4.32%) and dead
cells (10.51% vs. control 5.39%)
Decrease in tumor volume in C57BL/6J mice with
B164A5 cells inoculation;
Reduced expression of S100 and VEGF in Bet:GCDG
1:1 treated mice
Soica C. et al., 2012
Carbon nanotubes
loaded with betulin
No significant cytotoxic effect on J774A.1 macrophage
cell line (IC50 value is 72.63 ± 6.14 µg/ml.)
Saudagar and Dubey,
2014
Poly-D,L-lactide
nanovectors (PLA NVs)
with encapsulated
betulin
Anticancerous activity against cervical carcinoma SiHa
cells (up to 80% cell inhibition following 72 h incubation)
Yadav et al., 2016
Gold nanoparticles
conjugated with betulin
Antiproliferative activity against B164A5 (30–40% viable
cells), A375 (30–35% viable cells)
Current paper
nanoparticles, compounds that to the best of our knowledge
were prepared for the first time and represent one of the novelty
elements of our study. Furthermore, we consider this type of
nanoformulation to be superior, in terms of drug loading/release,
to other formulations containing triterpenes such as drug-
cyclodextrin complexes. In a previous work we reported the
formulation of a betulin complex with a cyclodextrin derivative
containing hydrophobic substituents that showed a very high
stability constant, which impeded drug release at the targeted
location (Soica C. et al., 2012). Considering their large surface
area available for molecule binding and relatively weak drug-
nanoparticle interactions (Huo et al., 2013), spherical gold
nanoparticles could provide improved quantitative drug release
at the tumor site.
Our data showed that the nanoparticles loaded with betulin
(both naked and coated with PEG) exhibited potent cytotoxic
effects against melanoma cells in a dose and time-dependent
manner, the human melanoma cells being more sensitive to
their toxic effects. Another very important finding was that
these nanoparticles showed significant cytotoxicity compared to
betulin (when tested under the same experimental conditions in
terms of concentration and time points of incubation). The most
significant cytotoxic effects against A375 were recorded at 48 h
post-stimulation, whereas in the case of B164A5 cells the toxicity
was more prominent after 72 h treatment (Figure 5). In addition,
the current study furnishes important information regarding
the impact of betulin loaded gold nanoparticles on human
keratinocytes and fibroblasts, as follows: HaCaT cells viability was
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affected in a dose and time-dependent manner after both type
of nanoparticles, but did not decrease under 50%, albeit 1BR3
proved to be very sensitive to these nanoparticles, the cytotoxic
effect being dose-dependent and visible after 24 h (Figure 6). The
results are in line with the ones obtained from Annexin V/PI
analysis which revealed that betulin loaded nanoparticles induced
a potent apoptotic effect for all the cell lines.
CONCLUSION
Present study reported the synthesis, characterization and
biological activity assessment of various surface modified betulin
conjugated gold nanoparticles. The compounds synthesized via
reduction method using trisodium citrate as reducing agent and
chloroauric acid as gold precurssor, presented a stable size that
was confirmed by various techniques. Average dimension for
all types of synthesized gold nanoparticles was around values
of 14–15 nm (measurement related only to the metallic core
regardless of the modified surface). On the other hand, according
to DLS measurements, larger diameters of nanoparticles were
obtained, ranging from 50 to 70 nm (dependent on the type of
nanoparticle synthesized). The differences between final products
are dependent on different causality factors responsible for the
size gap using the different methods, the presence of an electric
dipole at the metallic surface, as a result of water dispersion
(for naked AuNPs) or the presence of a modified surface with
large molecules (PEG-SH). The in vitro evaluation of the tested
samples indicated that betulin-conjugated gold nanoparticles
determined a cytotoxic and apoptotic effect in a dose-dependent
manner on all cell lines and is dependent also on exposure time.
Naked AuNP or coated with Peg modified only slightly cells
viability.
Betulin conjugated gold nanoparticles can be considered a
new therapeutic strategy for patients with melanoma. Further
in vivo studies will be performed in order to establish the effect
in experimental models of skin cancer.
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